Reagents base plus 1 option year

Ended Awarded Last action

Contract number
N0025919F0174
Awardee
Awarding agency
Obligated
$227,628

Award facts

Contract value 100% obligated
$227,628.11 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Norcross, GA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 · The purpose of this modification is to add funding for option year 1. $113,872
Exercise an Option P00004 · Exercise option year 1, clins 1001-1013, 1015-1019, 1021-1036. $0
Supplemental Agreement for work within scope P00003 · Change clin 0033 and clin 1033 from discontinued item 0007594 to replacement item 0004818. There are no changes to funding. $0
Supplemental Agreement for work within scope P00002 · Decrease clin 0014 and cancel 1014 to replace with clin 0036 and 1036. $184
Funding Only Action P00001 · Remove QTY for reagents that are no longer needed. -$1,297
Original award $114,870

About this award

This is a Delivery Order contract awarded to Immucor Inc., a manufacturer of in vitro diagnostic reagents, test kits, and blood banking equipment. The contract was awarded by the Defense Health Agency (DHA) for $227,628.11 and has a period of performance ending on September 30, 2021. The contract is not designated as a set-aside. Immucor provides specialized reagents, blood analyzers, and related consumables to enable blood typing, compatibility testing, antibody screening, and critical blood banking operations within military treatment facilities and federal health networks. This award is under Immucor's existing General Services Administration (GSA) Multiple Award Schedule contract for in vitro diagnostics, reagents, and tests. Immucor has a history of providing these types of products and services to government agencies such as the Department of Veterans Affairs and Indian Health Service through a variety of contract vehicles, including indefinite delivery contracts and GSA Blanket Purchase Agreements.

Quick answers

Who was awarded contract N0025919F0174?

N0025919F0174 was awarded to Immucor Inc. by Bureau of Medicine and Surgery (Department of the Navy) on September 24, 2019.

How much is contract N0025919F0174 worth?

The government has obligated $227,628 on N0025919F0174.

Which agency awarded contract N0025919F0174?

Bureau of Medicine and Surgery (Department of the Navy) awarded N0025919F0174, with funding from Defense Health Agency (Department of Defense).

Is contract N0025919F0174 an order under another contract?

Yes. N0025919F0174 is a delivery order under V797D70110, a federal supply schedule, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).

Was contract N0025919F0174 competed?

The extent of competition for N0025919F0174 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award